We report the development of a highly sensitive ratiometric fluorescent lateral flow
immunoassay (RFLFIA) strip for rapid and accurate detection of acute myocardial infarction …

Lateral flow assays (LFAs) have become the most common biosensing platforms for point-of-
care testing due to their compliance with the ASSURED (affordable, sensitive, specific, user …

Lateral flow immunoassays (LFIAs) have been employed extensively for the rapid, accurate,
and portable detection of protein biomarkers in healthcare. However, the cross-reactivity …

Herein, we report a novel lateral flow immunoassay (LFIA) system for detecting cardiac
troponin I (cTnI) in serum using the time-resolved fluorescence resonance energy transfer …

Immunological detection of small molecules in a point-of-care (POC) format is of great
significance yet remains challenging for accurate visual discrimination and quantitative …

Lateral flow immunoassay (LFIA) is a rapid, simple, and inexpensive point‐of‐need method.
A major limitation of LFIA is a high limit of detection (LOD), which impacts its diagnostic …

The ability to rapidly identify diseases enables prompt treatment and improves outcomes.
This possibility has increased the development and use of rapid point-of-care diagnostic …

BACKGROUND Although numerous lateral flow immunoassays (LFIAs) have been
developed and widely used, inadequate analytical sensitivity and the lack of multiple protein …

The formation of atherosclerotic plaques is the root cause of various cardiovascular
diseases (CVDs). Effective CVD interventions thus call for precise identification of the …

At present, enzyme-linked immunosorbent assay (ELISA) is considered to be the most
appropriate approach in clinical biomarker detection, with good specificity, low cost, and …